Learn key considerations for the use of current and future novel therapies including as prevention, initial treatment, switch strategies, and in heavily-treatment experienced patients with HIV.
Cristina Mussini, MD
William R. Short, MD, MPH, AAHIVS
Format: Microsoft PowerPoint (.ppt)
File Size: 3.21 MB
Released: April 15, 2022
Acknowledgements
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare
Leaving the CCO site
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
